Comprehensive analysis of autophagy-related prognostic genes in breast cancer

被引:18
作者
Lai, Jianguo [1 ]
Chen, Bo [1 ]
Mok, Hsiaopei [1 ]
Zhang, Guochun [1 ]
Ren, Chongyang [1 ]
Liao, Ning [1 ]
机构
[1] Guangdong Prov Peoples Hosp & Guangdong Acad Med, Ctr Canc, Dept Breast Canc, 106 Zhongshan Er Rd, Guangzhou 510080, Peoples R China
基金
中国国家自然科学基金;
关键词
autophagy; breast cancer; gene; model; prognosis; IDENTIFICATION; SIGNATURE; SURVIVAL; TARGET;
D O I
10.1111/jcmm.15551
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Accumulating evidence revealed that autophagy played vital roles in breast cancer (BC) progression. Thus, the aim of this study was to investigate the prognostic value of autophagy-related genes (ARGs) and develop a ARG-based model to evaluate 5-year overall survival (OS) in BC patients. We acquired ARG expression profiling in a large BC cohort (N = 1007) from The Cancer Genome Atlas (TCGA) database. The correlation between ARGs and OS was confirmed by the LASSO and Cox regression analyses. A predictive model was established based on independent prognostic variables. Thus, time-dependent receiver operating curve (ROC), calibration plot, decision curve and subgroup analysis were conducted to determine the predictive performance of ARG-based model. Four ARGs (ATG4A, IFNG, NRG1 and SERPINA1) were identified using the LASSO and multivariate Cox regression analyses. A ARG-based model was constructed based on the four ARGs and two clinicopathological risk factors (age and TNM stage), dividing patients into high-risk and low-risk groups. The 5-year OS of patients in the low-risk group was higher than that in the high-risk group (P < 0.0001). Time-dependent ROC at 5 years indicated that the four ARG-based tool had better prognostic accuracy than TNM stage in the training cohort (AUC: 0.731 vs 0.640,P < 0.01) and validation cohort (AUC: 0.804 vs 0.671,P < 0.01). The mutation frequencies of the four ARGs (ATG4A, IFNG, NRG1 and SERPINA1) were 0.9%, 2.8%, 8% and 1.3%, respectively. We built and verified a novel four ARG-based nomogram, a credible approach to predict 5-year OS in BC, which can assist oncologists in determining effective therapeutic strategies.
引用
收藏
页码:9145 / 9153
页数:9
相关论文
共 45 条
  • [1] Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers
    Anurag, Meenakshi
    Punturi, Nindo
    Hoog, Jeremy
    Bainbridge, Matthew N.
    Ellis, Matthew J.
    Haricharan, Svasti
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4887 - 4899
  • [2] Nomograms in oncology: more than meets the eye
    Balachandran, Vinod P.
    Gonen, Mithat
    Smith, J. Joshua
    DeMatteo, Ronald P.
    [J]. LANCET ONCOLOGY, 2015, 16 (04) : E173 - E180
  • [3] CAMP RL, 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]
  • [4] SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients
    Chan, Hei Jason
    Li, Haiqing
    Liu, Zheng
    Yuan, Yate-Ching
    Mortimer, Joanne
    Chen, Shiuan
    [J]. ONCOTARGET, 2015, 6 (28) : 25815 - 25827
  • [5] Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
    Chen, Bo
    Tang, Hailin
    Chen, Xi
    Zhang, Guochun
    Wang, Yulei
    Xie, Xiaoming
    Liao, Ning
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 179 - 190
  • [6] Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis
    Chen, Qing
    Yu, Dongmei
    Zhao, Yingying
    Qiu, Jiajun
    Xie, Yufeng
    Tao, Min
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (12) : 19496 - 19508
  • [7] Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.7326/M14-0697, 10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0698, 10.1186/s12916-014-0241-z, 10.1038/bjc.2014.639, 10.1016/j.eururo.2014.11.025, 10.1002/bjs.9736, 10.1136/bmj.g7594]
  • [8] Selective Autophagy in Cancer Development and Therapy
    Dikic, Ivan
    Johansen, Terje
    Kirkin, Vladimir
    [J]. CANCER RESEARCH, 2010, 70 (09) : 3431 - 3434
  • [9] Decision Curve Analysis
    Fitzgerald, Mark
    Saville, Benjamin R.
    Lewis, Roger J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (04): : 409 - 410
  • [10] Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update
    Giordano, Sharon H.
    Temin, Sarah
    Chandarlapaty, Sarat
    Crews, Jennie R.
    Esteva, Francisco J.
    Kirshner, Jeffrey J.
    Krop, Ian E.
    Levinson, Jennifer
    Lin, Nancy U.
    Modi, Shanu
    Patt, Debra A.
    Perlmutter, Jane
    Ramakrishna, Naren
    Winer, Eric P.
    Davidson, Nancy E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (26) : 2736 - +